| Name | 3-(2-Amino-1,3-thiazol-4-yl)benzonitrile |
|---|---|
| Synonyms | MFCD03407827 |
| Molecular Formula | C10H7N3S |
|---|---|
| Molecular Weight | 201.24800 |
| Exact Mass | 201.03600 |
| PSA | 90.94000 |
| LogP | 2.84518 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934100090 |
|
~70%
202664-32-2 |
| Literature: Bristol-Myers Squibb Company Patent: US2009/75995 A1, 2009 ; Location in patent: Page/Page column 52-53 ; |
|
~%
202664-32-2 |
| Literature: Hoffmann-La Roche Inc. Patent: US5877193 A1, 1999 ; |
|
~%
202664-32-2 |
| Literature: GLAXO GROUP LIMITED; WANG, Yonghui; YANG, Ting Patent: WO2012/100734 A1, 2012 ; WO 2012/100734 A1 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |